Vyant Bio Retains Skyline Corporate Communications Group, LLC to Provide Investor Relations Services
01 juin 2022 18h05 HE
|
Vyant Bio, Inc.
CHERRY HILL, N.J., June 01, 2022 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio” or “Company”) (Nasdaq: VYNT) is an innovative biotechnology company reinventing drug discovery for complex...
Vyant Bio to Present at the H.C. Wainwright Global Investment Hybrid Conference
19 mai 2022 08h30 HE
|
Vyant Bio, Inc.
Cherry Hill, N.J., May 19, 2022 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio” or “Company”) (Nasdaq: VYNT), is an innovative biotechnology company reinventing drug discovery for complex...
Vyant Bio Reports First Quarter 2022 Results and Provides Strategic and Business Highlights
16 mai 2022 08h30 HE
|
Vyant Bio, Inc.
Conference Call and Webcast Today at 4:30 pm ET Scientific and Business Highlights ●Progress in the discovery of small molecule therapeutics to treat neurodevelopmental and...
Vyant Bio Announces Investor Conference Call and Webcast for the First Quarter 2022
10 mai 2022 16h01 HE
|
Vyant Bio, Inc.
CHERRY HILL, N.J., May 10, 2022 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio”, “Company”) (Nasdaq: VYNT) is an innovative biotechnology company reinventing drug discovery for complex...
Vyant Bio Announces Participation in BioNJ’s 12th Annual BioPartnering Conference
05 mai 2022 16h30 HE
|
Vyant Bio, Inc.
CHERRY HILL, N.J., May 05, 2022 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio”, “Company”) (Nasdaq: VYNT), an innovative biotechnology company reinventing drug discovery for complex...
Vyant Bio Reports Fourth Quarter and Year-End 2021 Results and Provides Strategic and Business Highlights
30 mars 2022 07h50 HE
|
Vyant Bio, Inc.
Highlights Focused as a pure-play drug discovery and development biotechnology companyPrimary work on the discovery of small molecule therapeutics to treat neurodevelopmental and neurodegenerative...
Vyant Bio and OrganoTherapeutics Announce Strategic Collaboration to Discover Therapeutics to Treat Parkinson’s Disease
29 mars 2022 17h00 HE
|
Vyant Bio, Inc.
Cherry Hill, N.J. and Esch-sur-Alzette, Luxembourg, March 29, 2022 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio”, “Company”) (Nasdaq: VYNT), an innovative biotechnology company reinventing drug...
Vyant Bio Announces Investor Conference Call and Webcast for the Year-End 2021
28 mars 2022 16h30 HE
|
Vyant Bio, Inc.
CHERRY HILL, N.J., March 28, 2022 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio”, “Company”) (Nasdaq: VYNT), is an innovative biotechnology company reinventing drug discovery for complex...
Vyant Bio to Present at the H.C. Wainwright Bioconnect Conference
10 janv. 2022 08h00 HE
|
Vyant Bio, Inc.
Cherry Hill, N.J., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio”, “Company”) (Nasdaq: VYNT), an emerging global drug discovery company, is rapidly identifying small and large...
Vyant Bio to Present at the Q4 Investor Summit Micro & Small Cap Conference
10 nov. 2021 16h15 HE
|
Vyant Bio, Inc.
Cherry Hill, N.J., Nov. 10, 2021 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio”, “Company”) (Nasdaq: VYNT), an emerging global drug discovery company, is rapidly identifying small and large...